Press Releases
First Farmers and Merchants Corporation (OTC Pink: FFMH), the holding company for First Farmers and Merchants Bank, today announced its results for the first quarter of 2025.
By First Farmers and Merchants Corporation · Via Business Wire · April 28, 2025
Clasp Therapeutics, a biotechnology company bringing unparalleled precision to immuno-oncology using next-generation T-cell engagers (TCEs), today announced dosing of the initial patient in the GUARDIAN-101 phase 1 trial of CLSP-1025, the first tumor-specific TCE to enter clinical development. CLSP-1025 exclusively targets cancer cells expressing the p53R175H mutation, a mutation associated with a wide range of solid tumors, including colorectal, pancreatic, lung, gastric, esophageal, gynecological, and prostate cancers.
By Clasp Therapeutics · Via Business Wire · April 28, 2025
Graylog, the no-nonsense platform for Security, API protection, and IT Operations, today launched its Spring 2025 release of Graylog Security—pushing further past the limits of traditional SIEM. Building on the Fall 2024 release (version 6.1), Graylog sharpens analyst workflows, accelerates time-to-value, and sets a new bar for speed and flexibility in threat detection.
By Graylog · Via Business Wire · April 28, 2025
WireDaily has released a new guide on Hamilton Gold Group Reviews and Complaints for consumers.
Via ACCESS Newswire · April 28, 2025
WireDaily has published a new analysis on Monetary Gold's reviews and complaints for 2025.
Via ACCESS Newswire · April 28, 2025
By HKTDC · Via ACN Newswire · April 28, 2025
Ziff Davis, Inc. (NASDAQ: ZD) today announced its participation in one investor conference in May.
By Ziff Davis, Inc. · Via Business Wire · April 28, 2025
H Partners Management, LLC (“H Partners” or “we”), one of the largest shareholders of Harley-Davidson, Inc. (NYSE: HOG) (“Harley-Davidson” or the “Company”), which beneficially owns approximately 9.1% of the outstanding shares of the Company, today announced that it has filed a definitive proxy statement with the U.S. Securities and Exchange Commission in connection with its campaign to urge shareholders to vote “WITHHOLD” on the election of three long-tenured incumbent directors – CEO and Chairman Jochen Zeitz, Presiding Director Thomas Linebarger, and 29-year director Sara Levinson – at the Company’s 2025 Annual Meeting of Shareholders (the “Annual Meeting”) scheduled for May 14, 2025.
By H Partners Management, LLC · Via Business Wire · April 28, 2025
MILAN, April 28, 2025 (GLOBE NEWSWIRE) -- AAVantgarde Bio (AAVantgarde), a clinical-stage, international biotechnology company with two proprietary Adeno-Associated Viral (AAV) vector platforms for large gene delivery, today announced the appointment of Mr. Rasmus Holm-Jorgesen as their Chief Financial Officer (CFO). Rasmus brings over 25 years of experience in strategy, finance and global operations within the biopharmaceutical industry to AAVantgarde and has joined the Company’s leadership team, reporting to Dr Natalia Misciattelli, Chief Executive Officer.
By AAVantgarde · Via GlobeNewswire · April 28, 2025
WATERTOWN, Mass., April 28, 2025 (GLOBE NEWSWIRE) -- Neumora Therapeutics, Inc. (Nasdaq: NMRA), a clinical-stage biopharmaceutical company with a therapeutics pipeline consisting of seven brain disease programs including two clinical-stage programs, today announced that it will host a conference call and live webcast at 4:30 p.m. ET on Monday, May 12, 2025 to report its first quarter 2025 financial results and provide a business update.
By Neumora Therapeutics, Inc. · Via GlobeNewswire · April 28, 2025
LONDON and PHOENIX, Ariz., April 28, 2025 (GLOBE NEWSWIRE) -- AccuStem Sciences, Inc. (OTCQB: ACUT), a clinical stage diagnostics company dedicated to improving outcomes for patients with or at risk of cancer, and EmeritusDX, a rapidly growing cancer diagnostics and information company, are pleased to announce the expansion of their strategic partnership to include the commercialization of the MSC test for lung cancer screening. This collaboration aims to enhance the accuracy of lung nodule stratification identified via low-dose computed tomography (LDCT), thereby improving patient outcomes and reducing healthcare costs.
By AccuStem Sciences, Inc. · Via GlobeNewswire · April 28, 2025
All financial results are reported in Canadian dollars, unless otherwise stated.
By Cannara Biotech (Québec) Inc. · Via GlobeNewswire · April 28, 2025
ROCKVILLE, Md. and SUZHOU, China, April 28, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global biopharmaceutical company engaged in discovering, developing, and commercializing therapies to address global unmet medical needs primarily for hematological malignancies, today announced that it has presented results from five preclinical studies during poster presentations at the 2025 American Association for Cancer Research (AACR) Annual Meeting, taking place April 25-30, 2025, in Chicago, Illinois, USA.
By ASCENTAGE PHARMA GROUP INTERNATIONAL · Via GlobeNewswire · April 28, 2025
EXTON, Pa., April 28, 2025 (GLOBE NEWSWIRE) -- This spring, Lungpacer Medical clinical experts and device innovators will be featured presenters at top industry events. Speakers will demonstrate how novel interventional therapies can free critically ill patients from mechanical ventilation and may help improve lung, heart, and brain health in ventilated patients.
By Lungpacer Medical USA Inc. · Via GlobeNewswire · April 28, 2025
FAP-EXd (AVA6103) demonstrates tumor growth inhibition and durable complete responses in multiple therapy-resistant preclinical models
By AVACTA GROUP PLC · Via GlobeNewswire · April 28, 2025
Lead development candidate, AMP-410, leverages proprietary Ampersand technology to block VEGF and allosterically activate 4-1BB signaling – unlike traditional bispecific molecules – driving both adaptive and innate anti-tumor activity
By Ampersand Biomedicines · Via GlobeNewswire · April 28, 2025
FRIENDSWOOD, Texas, April 28, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced its achievement of surpassing a significant milestone of 200,000 DecisionDx-Melanoma clinical test orders. DecisionDx-Melanoma is a 31-gene expression profile test that provides comprehensive, personalized results designed to improve risk-aligned management decisions for patients with stage I-III cutaneous melanoma.
By Castle Biosciences, Inc. · Via GlobeNewswire · April 28, 2025
Opal Coalbank consists of nine DUC wells on track for production this summer
By Prairie Operating Co. · Via GlobeNewswire · April 28, 2025
NEW YORK, April 28, 2025 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced that it will report its first quarter 2025 financial results and provide a business update on Monday, May 5, 2025.
By Syndax Pharmaceuticals, Inc. · Via GlobeNewswire · April 28, 2025
(All dollar amounts are expressed in CAD dollars, unless stated otherwise)
By Osisko Development Corp. · Via GlobeNewswire · April 28, 2025
Approval Supports Revenue Growth and Margin Expansion Opportunity, and Substantially Increases Peak Production Output Capacity
By ADMA Biologics, Inc. · Via GlobeNewswire · April 28, 2025
Portland Brewery Marks Four Decades of Widmer Beer with ‘40 Years of Cheers’ and Re-release of Four Iconic Brews
By Tilray Brands, Inc. · Via GlobeNewswire · April 28, 2025
Beamr will present at the Ladenburg Thalmann Technology Innovation Expo in New York, and participate virtually in the Needham 1x1 Conference Herzliya, Israel, April 28, 2025 (GLOBE NEWSWIRE) -- Beamr Imaging Ltd. (NASDAQ: BMR), a leader in video optimization technology and solutions, today announced the Company will participate in the following investor conferences:
By Beamr Imaging Ltd. · Via GlobeNewswire · April 28, 2025
NEWTON, Mass., April 28, 2025 (GLOBE NEWSWIRE) -- Auron Therapeutics, a clinical-stage biotechnology company targeting cell-state plasticity to improve patient outcomes in oncology and inflammatory disease, today announced preclinical data in prostate cancer at the American Association for Cancer Research (AACR) Annual Meeting in Chicago, IL.
By Auron Therapeutics Inc. · Via GlobeNewswire · April 28, 2025
MARYSVILLE, Ohio, April 28, 2025 (GLOBE NEWSWIRE) -- The Scotts Miracle-Gro Company (NYSE: SMG), the world’s leading marketer of branded consumer lawn and garden products as well as a leader in indoor and hydroponic growing products, reported that Chairman and CEO Jim Hagedorn announced during an April 25 appearance on CNBC Mad Money that the Company is driving strong consumer takeaway in the run-up to the peak lawn and garden season.
By Scotts Miracle-Gro Company (The) · Via GlobeNewswire · April 28, 2025
CDK2 molecular glue degrader (MGD) in combination with CDK4/6 inhibition and anti-estrogen therapy achieved superior tumor regression in vivo compared to standard of care CDK4/6 inhibition and anti-estrogen therapy
By Monte Rosa Therapeutics, Inc. · Via GlobeNewswire · April 28, 2025
CHICAGO and VANCOUVER, British Columbia, April 28, 2025 (GLOBE NEWSWIRE) -- RISE Dispensaries, a rapidly growing cannabis retail chain owned by Green Thumb Industries Inc. (“Green Thumb” or the “Company”) (CSE: GTII) (OTCQX: GTBIF), today announced that RISE Dispensary Ocala, the Company’s 22nd retail location in Florida and 104th nationwide, will open on April 29. Located at 3873 SW College Road, the dispensary will offer medical patients a diverse collection of cannabis products from brands including RYTHM, Dogwalkers, &Shine, Good Green, and Doctor Solomon’s. As part of RISE and Green Thumb’s ongoing commitment to supporting local communities, RISE Dispensary Ocala will donate a portion of one day’s profits to community-based organization The Bridge 4 Veterans.
By Green Thumb Industries · Via GlobeNewswire · April 28, 2025
NEW HAVEN, Conn., April 28, 2025 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company working to develop a new class of drugs based on targeted protein degradation, today announced that management will review first quarter 2025 financial results and provide a corporate update during a live webcast on Thursday, May 1, 2025, at 8:00 a.m. ET.
By Arvinas Inc. · Via GlobeNewswire · April 28, 2025
TORONTO, April 28, 2025 (GLOBE NEWSWIRE) -- Barrick Gold Corporation (NYSE:GOLD)(TSX:ABX) (“Barrick” or the “Company”) today announced that it plans to change its name to Barrick Mining Corporation and from « Société aurifère Barrick » to « Société minière Barrick » in French, subject to shareholder approval at its upcoming Annual and Special Meeting of Shareholders on May 6, 2025.
By Barrick Gold Corporation · Via GlobeNewswire · April 28, 2025
Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of SpringWorks Therapeutics, Inc. (NASDAQ: SWTX) to Merck KGaA, Darmstadt, Germany for $47.00 per share in cash is fair to SpringWorks shareholders.
By Halper Sadeh LLC · Via Business Wire · April 28, 2025
At the TEAMZ 2025 Web3/AI Summit in Tokyo, ENI showcased its enterprise blockchain innovations. As a ZK-driven modular ecosystem, its new high-performance Layer 1 architecture achieves 10,000 TPS throughput. A three-layer composite consensus mechanism, combined with a ZK coprocessor, addresses traditional blockchain pain points in performance, privacy, and scalability. This provides secure and efficient solutions for scenarios like cross-border trade, reshaping the global commercial trust network.
Via Binary News Network · April 28, 2025
Ryder System, Inc. (NYSE: R) launches a national television ad campaign, “Stories from the Supply Chain,” showcasing real businesses navigating logistics challenges in an ever-shifting supply chain environment. From fashion to fine wines and spirits, the initial campaign highlights two Ryder customers – Mugsy and Southern Glazer’s Wine & Spirits – candidly recounting the moments they realized it was time to call the supply chain experts.
By Ryder System, Inc. · Via Business Wire · April 28, 2025
Increasing full year guidance
By Roper Technologies, Inc. · Via GlobeNewswire · April 28, 2025
At Paris Blockchain Week 2025, CoinW expanded its international presence and strengthened industry ties through strategic engagements and sponsorships. The platform partnered with Solana to launch a four-week Super Team Hackathon focused on DeFi and DePIN, supporting blockchain developers with mentorship and resources. This initiative highlights CoinW’s commitment to fostering innovation and ecosystem growth in the global blockchain community.
Via Binary News Network · April 28, 2025
CoinW and the Sui Foundation wrapped up their month-long WConnect x Sui Season with a Twitter Space event focusing on Sui’s technology, ecosystem expansion, and market strategies. Featuring experts from Mysten Labs and CoinW, the discussion highlighted Sui’s innovations and CoinW’s efforts to support blockchain developers through WConnect. The initiative aims to foster collaboration and accelerate growth in the Web3 ecosystem.
Via Binary News Network · April 28, 2025
Scholar Rock (NASDAQ: SRRK), a late-stage biopharmaceutical company focused on advancing innovative treatments for neuromuscular diseases, cardiometabolic disorders, and other serious diseases, announced today that David Hallal has been appointed Chief Executive Officer succeeding Jay Backstrom, M.D. David Hallal has served as Chairman of the Board at Scholar Rock since 2017 and just prior to that spent more than a decade as CEO, COO, and CCO of Alexion building and leading the company’s 50-country operating platform. As part of this planned transition, Dr. Backstrom will serve as a strategic advisor, working closely with the company’s executive team and Board of Directors.
By Scholar Rock · Via Business Wire · April 28, 2025
- NDA submitted for the treatment of central diabetes insipidus -- Expected 10-month review; commercial preparations underway for a potential Q1 2026 launch –
By Eton Pharmaceuticals · Via GlobeNewswire · April 28, 2025
– ARV-393 demonstrated strong synergistic antitumor activity, including complete regressions, in combination with standard-of-care chemotherapy, biologics, and select investigational oral small molecule inhibitors –
By Arvinas Inc. · Via GlobeNewswire · April 28, 2025
Rithm Property Trust Inc. (NYSE: RPT, “Rithm Property Trust” or the “Company”) today announced the following information for the quarter ended March 31, 2025.
By Rithm Property Trust Inc. · Via Business Wire · April 28, 2025
BankUnited, Inc. (the “Company”) (NYSE: BKU) today announced financial results for the quarter ended March 31, 2025.
By BankUnited, Inc. · Via Business Wire · April 28, 2025
Lindsay Corporation (NYSE: LNN), a leading global manufacturer and distributor of irrigation and infrastructure equipment and technology, today announced that Randy Wood, President and Chief Executive Officer, and Brian Ketcham, Senior Vice President and Chief Financial Officer, will present on an investment panel at the Gabelli Funds 16th Annual Value Investor Conference, being held May 2nd at The Hilton Omaha in Omaha, NE.
By Lindsay Corporation · Via Business Wire · April 28, 2025
The 2025 Global AI + Blockchain Industry Innovation Summit and AIX Global Launch Conference concluded successfully, marking a significant step forward for the next generation of digital financial infrastructure. The summit, themed “Empowering New Finance with Intelligent Technology, A New Era of Blockchain,” gathered top global technology leaders, investment institutions, industry experts, and media representatives. They collectively explored the cutting-edge trends in the integration of AI and blockchain and witnessed the global launch of AIX, the world’s first Web3 ecosystem platform driven by AI Agents.
Via Binary News Network · April 28, 2025
In celebration of National Nurses Week, kicking off Monday, May 6, 2025, Blue Sky Scrubs is launching a heartfelt giveaway to honor the incredible nurses and healthcare workers who care for our communities every day. The luxury scrub apparel brand is giving away 100 free scrub caps—no purchase required—as a small token of appreciation for their big impact.
Via Binary News Network · April 28, 2025
VICTORIA, Seychelles, April 28, 2025 (GLOBE NEWSWIRE) -- The global cryptoc exchange BYDFi officially listed the SIGN token and opened trading for the SIGN/USDT spot pair. To celebrate the launch, BYDFi has introduced a $5,000 prize pool, open to all participating traders.
By BYDFi Blockchain Limited · Via GlobeNewswire · April 28, 2025
Q1 2025 Operational and Financial HighlightsGold equivalent ounce ("GEO") production of 9,082 GEOs and sales of 8,034 GEOs for Q1...
Via Newsfile · April 28, 2025
Hyatt Hotels Corporation (“Hyatt” or the “Company”) (NYSE: H), a leading global hospitality company, announced today that HI Holdings Playa B.V., an indirect wholly owned subsidiary of Hyatt (“Buyer”), has extended the offering period of its previously announced cash tender offer to purchase all of the outstanding ordinary shares of Playa Hotels & Resorts N.V. (“Playa”) (NASDAQ: PLYA) for $13.50 per share in cash, less any applicable withholding taxes and without interest. The offer is being made pursuant to the previously announced purchase agreement, dated February 9, 2025 (the “Purchase Agreement”), among Hyatt, Buyer and Playa.
By Hyatt Hotels Corporation · Via Business Wire · April 28, 2025
Perfect Corp. (NYSE: PERF) (“Perfect” or the “Company”), a leading artificial intelligence (“AI”) company offering AI and augmented reality (“AR”) powered solutions to beauty and fashion industries, today announced its unaudited financial results for the three months ended March 31, 2025.
By Perfect Corp. · Via Business Wire · April 28, 2025
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that it will release financial results for the first quarter ended March 31, 2025, and provide an update on recent developments, on May 8, 2025.
By Compass Pathfinder Limited · Via Business Wire · April 28, 2025
Seoul, Seoul, Korea South, 28th Apr 2025 — NEXUS, led by CEO Henry Chang , has officially launched its first blockchain-based game, Ragnarok: Monster World , on the CROSS protocol. Developed by 0x& , the title marks a significant step forward in NEXUS’s commitment to blending renowned intellectual properties with cutting-edge blockchain technology, while delivering a seamless multi-chain gaming experience.
Via Binary News Network · April 28, 2025
Signature of the Rafale Marine contract for India
By Dassault Aviation · Via GlobeNewswire · April 28, 2025